The Technical Analyst
Select Language :
Elevation Oncology, Inc. [ELEV]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Elevation Oncology, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Elevation Oncology, Inc. is listed at the  Exchange

2.60% $5.14

America/New_York / 28 mar 2024 @ 09:55


Elevation Oncology, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 250.07 mill
EPS: -1.340
P/E: -3.84
Earnings Date: May 02, 2024
SharesOutstanding: 48.65 mill
Avg Daily Volume: 3.12 mill
RATING 2024-03-27
B+
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Neutral
DE: Strong Buy
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/a
Ebit
Asset
Debtn/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -3.84 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.65x
Company: PE -3.84 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$0.561
(-89.09%) $-4.58
Date: 2024-03-28
Expected Trading Range (DAY)

$ 4.59 - 5.65

( +/- 10.31%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-16 Ferra Joseph J Jr Buy 12 562 Common Stock
2024-03-16 Ferra Joseph J Jr Sell 4 773 Common Stock
2024-03-16 Ferra Joseph J Jr Sell 12 562 Restricted Stock Unit
2024-02-29 Sandler Alan B. Buy 55 000 Stock Option (Right to Buy)
2024-02-29 Cherrington Julie M Buy 55 000 Stock Option (Right to Buy)
INSIDER POWER
71.65
Last 96 transactions
Buy: 15 904 291 | Sell: 39 693 676

Forecast: 11:34 - $5.03

Live Trading Signals (every 1 min)

Forecast 1: 10:04 - $5.17
Forecast 2: 10:54 - $5.06
Forecast 3: 11:34 - $5.03
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $5.14 (2.60% )
Volume 0.0514 mill
Avg. Vol. 3.12 mill
% of Avg. Vol 1.646 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Elevation Oncology, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Elevation Oncology, Inc.

RSI

Intraday RSI14 chart for Elevation Oncology, Inc.

Last 10 Buy & Sell Signals For ELEV

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$2.97N/AActive
Profile picture for
            Elevation Oncology, Inc.

ELEV

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Last 10 Buy Signals

Date Signal @
CTUSXMar 28 - 09:55$90.95
NXTMar 28 - 09:5157.53
ARRYMar 28 - 09:51$14.71
WENMar 28 - 09:49$18.73
ALNYMar 28 - 09:49$153.24
RBNUSDMar 28 - 09:461.600
GEHCMar 28 - 09:4689.80
ILMNMar 28 - 09:45$136.47
MDGLMar 28 - 09:43$256.11
UTHRMar 28 - 09:42$240.66

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.